SOMNF (SomnoMed) Other Current Liabilities: $2.67 Mil (As of Dec. 2025)


SOMNF SomnoMed Ltd SOMNF
53 GF Score
Price $0.45
GF Value $0.40
! 3 Warning Signs
View Full Analysis

What is SomnoMed Other Current Liabilities?

SomnoMed SOMNF 53 Other Current Liabilities is $2.67 Mil as of Dec. 2025. GuruFocus rates SOMNF with a GF Score™ of 53/100 and a GF Value™ of $0.40. The stock has 3 warning signs investors should review.

SomnoMed's other current liabilities for the quarter that ended in Dec. 2025 was $2.67 Mil.

SomnoMed's quarterly other current liabilities increased from Dec. 2024 ($2.80 Mil) to Jun. 2025 ($2.94 Mil) but then declined from Jun. 2025 ($2.94 Mil) to Dec. 2025 ($2.67 Mil).

SomnoMed's annual other current liabilities increased from Jun. 2023 ($3.00 Mil) to Jun. 2024 ($4.21 Mil) but then declined from Jun. 2024 ($4.21 Mil) to Jun. 2025 ($2.94 Mil).

SomnoMed Other Current Liabilities Related Terms

SomnoMed Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for SomnoMed's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Other Current Liabilities Chart

SomnoMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.52 3.74 3.00 4.21 2.94

SomnoMed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 4.21 2.80 2.94 2.67
SOMNF
53GF Score
SomnoMed Ltd SOMNF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SomnoMed Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $2.67 Mil mean?
SomnoMed (SOMNF) has a Other Current Liabilities of $2.67 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on SomnoMed.
Is SomnoMed's Other Current Liabilities too high?
SomnoMed's current Other Current Liabilities is $2.67 Mil. Overall, SomnoMed has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's Other Current Liabilities compare to ABT and SYK?
SomnoMed's Other Current Liabilities of $2.67 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on SomnoMed. SomnoMed's current Other Current Liabilities is $2.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
SomnoMed (SOMNF) has a current Other Current Liabilities of $2.67 Mil. The stock's GF Value™ is $0.40, compared to a current price of $0.45 — trading 12% above its estimated fair value. The current Other Current Liabilities is $2.67 Mil. SomnoMed's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For SomnoMed (SOMNF), the current Other Current Liabilities is $2.67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SomnoMed (SOMNF) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of $0.45 is trading 12% above its estimated GF Value™ of $0.40.

Key valuation signals for SOMNF:

  • Other Current Liabilities: $2.67 Mil
  • GF Value™: $0.40 vs. price of $0.45 (12% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges RJV:GermanySOM:Australia
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
53GF Score

Get the complete analysis for SOMNF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.45
Price
$0.40
GF Value